FDA Inspection 1204437 — Jan (NMI) Ernest, MUDr., Ph.D.
The FDA completed an inspection of Jan (NMI) Ernest, MUDr., Ph.D. on April 28, 2023 in Prague 5. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 28, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Prague 5 (Czech Republic)
Additional Details
Clinical Investigator (CI)